S. 2493 · 118th Congress
PBM Reporting Transparency Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 118th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
WarnerSponsor3 cosponsors · 1 D, 2 R
3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill requires the Medicare Payment Advisory Commission to report certain information about pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage.
What it does: CRS summary · Introduced in Senate · Jul 25, 2023
PBM Reporting Transparency Act
This bill requires the Medicare Payment Advisory Commission to report certain information about pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage.
Specifically, the commission must report on trends in agreements between PBMs and prescription drug plans, the impact of any differences in agreements on out-of-pocket spending for enrollees and pharmacy reimbursements, and any appropriate recommendations. The commission must submit an updated report two years after its initial report.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: PBM Reporting Transparency Act
Latest action (Jul 25, 2023): Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: Senate · Introduced: Jul 25, 2023
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.